8 stories mentioning ALHCUpdated 13d ago
Every FINWIRES story that references ALHC, newest first.
Dawn Christine Maroney, President, on July 15, 2026, sold 177,068 shares in Alignment Healthcare (ALHC) for $3,687,990. Following the Form 4 filing with the SEC, Maroney has control over a total of 922,313 common shares of the company, with 922,313 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026048498/xslF345X05/wk-form4_1784235242.xml
John E Kao, Director, Chief Executive Officer, on July 10, 2026, sold 298,000 shares in Alignment Healthcare (ALHC) for $5,919,361. Following the Form 4 filing with the SEC, Kao has control over a total of 2,697,509 common shares of the company, with 1,608,743 shares held directly and 1,088,766 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026048170/xslF345X05/wk-form4_1784062026.xml
Joseph S Konowiecki, Director, Executive Vice President, Corporate Affairs, on July 01, 2026, sold 25,000 shares in Alignment Healthcare (ALHC) for $600,000. Following the Form 4 filing with the SEC, Konowiecki has control over a total of 1,103,816 common shares of the company, with 1,103,816 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026046575/xslF345X05/wk-form4_1782938299.xml
Joseph S Konowiecki, Director, Executive Vice President, Corporate Affairs, on June 26, 2026, sold 25,000 shares in Alignment Healthcare (ALHC) for $575,000. Following the Form 4 filing with the SEC, Konowiecki has control over a total of 1,128,816 common shares of the company, with 1,128,816 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026045734/xslF345X05/wk-form4_1782504085.xml
Joseph S Konowiecki, Director, Executive Vice President, Corporate Affairs, on June 18, 2026, sold 25,000 shares in Alignment Healthcare (ALHC) for $550,000. Following the Form 4 filing with the SEC, Konowiecki has control over a total of 1,153,816 common shares of the company, with 1,153,816 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026044253/xslF345X05/wk-form4_1781812958.xml
John E Kao, Director, Chief Executive Officer, on June 10, 2026, sold 298,000 shares in Alignment Healthcare (ALHC) for $6,066,621. Following the Form 4 filing with the SEC, Kao has control over a total of 2,995,509 common shares of the company, with 1,608,743 shares held directly and 1,386,766 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026042824/xslF345X05/wk-form4_1781294599.xml
Alignment Healthcare (ALHC) reported Q1 earnings late Thursday of $0.05 per diluted share, compared with the loss of $0.05 a year earlier.Analysts polled by FactSet expected earnings of $0.01.Revenue in the three months ended March 31 rose to $1.24 billion from $926.9 million a year ago.Analysts surveyed by FactSet expected $1.22 billion.The company expects revenue of $1.3 billion to $1.32 billion in Q2 and $5.16 billion to $5.21 billion in the full year.Analysts project $1.31 billion in Q2 and $5.17 billion in 2026.Alignment Healthcare shares fell 10% in after-hours trading.
John E Kao, Director, Chief Executive Officer, on April 10, 2026, sold 298,000 shares in Alignment Healthcare (ALHC) for $6,161,943. Following the Form 4 filing with the SEC, Kao has control over a total of 3,591,509 common shares of the company, with 1,784,868 shares held directly and 1,806,641 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832466/000162828026024978/xslF345X05/wk-form4_1776119869.xml
